A detailed history of Health Invest Partners Ab transactions in Alkermes Plc. stock. As of the latest transaction made, Health Invest Partners Ab holds 68,800 shares of ALKS stock, worth $1.83 Million. This represents 1.04% of its overall portfolio holdings.

Number of Shares
68,800
Holding current value
$1.83 Million
% of portfolio
1.04%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$23.21 - $27.24 $1.6 Million - $1.87 Million
68,800 New
68,800 $1.66 Million

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.37B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Health Invest Partners Ab Portfolio

Follow Health Invest Partners Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Health Invest Partners Ab, based on Form 13F filings with the SEC.

News

Stay updated on Health Invest Partners Ab with notifications on news.